NCT00058097View on ClinicalTrials.gov

Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2007

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
Interventions
DRUG

tipifarnib

Given orally

RADIATION

radiation therapy

Undergo radiation therapy

Trial Locations (1)

21231-1000

New Approaches to Brain Tumor Therapy Consortium, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00058097 - Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter